(Q33372150)

26 July 2017

title

Valproate-associated coagulopathies are frequent and variable in children (English)

1 reference

26 July 2017

5

Carl-Erik Dempfle

1 reference

26 July 2017

Thorsten Gerstner

1

1 reference

26 July 2017

Martin Teich

2

1 reference

26 July 2017

Nellie Bell

3

1 reference

26 July 2017

Elke Longin

4

1 reference

26 July 2017

Joachim Brand

6

1 reference

26 July 2017

Stephan König

7

1 reference

26 July 2017

publication date

1 July 2006

1 reference

26 July 2017

1 reference

26 July 2017

volume

47

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

1136-1143

1 reference

Acute liver disease associated with sodium valproate

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Valproic-acid-induced pancytopenia and Coombs test positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Preoperative valproate administration does not increase blood loss during temporal lobectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Adenotonsillectomy in children with von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

The effect of valproic acid on blood loss in patients with cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Perioperative blood loss: the effect of valproate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Hematologic manifestations and impaired liver synthetic function during valproate monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Hematologic manifestations of long-term valproate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Thrombocytopenia associated with sodium valproate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

The platelet aggregation in children with epilepsy receiving valproic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Sodium valproate and bone marrow suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Valproate treatment and platelet function: the role of arachidonate metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Analysis of surgical blood loss and number of blood transfusions after temporal lobe resection performed in adults with epilepsy receiving valproate (VPA) in the immediate preoperative period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Post-operative central anticholinergic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Hematologic perturbations associated with salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Hippocampal Pyramidal Cell Loss in Human Status Epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Preparative isolation and characterization of the urinary aglycones of vitamin K1 (phylloquinone) in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00587.X

10.1111/J.1528-1167.2006.00587.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference